Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Oct 15;10(10):CD010859.
doi: 10.1002/14651858.CD010859.pub2.

Monotherapy laser photocoagulation for diabetic macular oedema

Eliane C Jorge  1 , Edson N Jorge, Mayra Botelho, Joyce G Farat, Gianni Virgili, Regina El Dib
Affiliations
Meta-Analysis

Monotherapy laser photocoagulation for diabetic macular oedema

Eliane C Jorge et al. Cochrane Database Syst Rev. .

Abstract

Background: Diabetic macular oedema (DMO) is a complication of diabetic retinopathy and one of the most common causes of visual impairment in people with diabetes. Clinically significant macular oedema (CSMO) is the most severe form of DMO. Intravitreal antiangiogenic therapy is now the standard treatment for DMO involving the centre of the macula, but laser photocoagulation is still used in milder or non-central DMO.

Objectives: To access the efficacy and safety of laser photocoagulation as monotherapy in the treatment of diabetic macular oedema.

Search methods: We searched CENTRAL, which contains the Cochrane Eyes and Vision Trials Register; MEDLINE; Embase; LILACS; the ISRCTN registry; ClinicalTrials.gov and the WHO ICTRP. The date of the search was 24 July 2018.

Selection criteria: We included randomised controlled trials (RCTs) comparing any type of focal/grid macular laser photocoagulation versus another type or technique of laser treatment and no intervention. We did not compare laser versus other interventions as these are covered by other Cochrane Reviews.

Data collection and analysis: We used standard methodological procedures expected by Cochrane. Our primary outcomes were gain or loss of 3 lines (0.3 logMAR or 15 ETDRS letters) of best-corrected visual acuity (BCVA) at one year of follow-up (plus or minus six months) after treatment initiation. Secondary outcomes included final or mean change in BCVA, resolution of macular oedema, central retinal thickness, quality of life and adverse events, all at one year. We graded the certainty of the evidence for each outcome using the GRADE approach.

Main results: We identified 24 studies (4422 eyes). The trials were conducted in Europe (nine studies), USA (seven), Asia (four) and, Africa (one), Latin America (one), Europe-Asian (one) and Oceania (one). The methodological quality of the studies was difficult to assess as they were poorly reported, so the predominant classification of bias was unclear.At one year, people with DMO receiving laser were less likely to lose BCVA compared with no intervention (risk ratio (RR) 0.42, 95% confidence interval (CI) 0.20 to 0.90; 3703 eyes; 4 studies; I2 = 71%; moderate-certainty evidence). There were also favourable effects observed at two and three years. One study (350 eyes) reported on partial or complete resolution of clinically significant DMO and found moderate-certainty evidence of a benefit at three years with photocoagulation (RR 1.55, 95% CI 1.30 to 1.86). Data on visual improvement, final BCVA, central macular thickness and quality of life were not available. One study related minor adverse effects on the central visual field and another reported one case of iatrogenic premacular fibrosis.Nine studies compared subthreshold versus standard macular photocoagulation (517 eyes). Subthreshold treatment was achieved with different methods of photocoagulation: non-visible conventional (two studies), micropulse (four) or nanopulse (one).Only one small study (29 eyes) reported on improvement or worsening of BCVA and estimates were very imprecise (improvement: RR 0.31, 95% CI 0.01 to 7.09; worsening: RR 0.93, 95% CI 0.15 to 5.76; very low-certainty evidence). All studies reported on continuous BCVA at one year; there was low-certainty evidence of no important difference between subthreshold and standard photocoagulation (mean difference (MD) in logMAR BCVA -0.02, 95% CI -0.07 to 0.03; 385 eyes; 7 studies; I2 = 42%), and were possibly different for different techniques (P = 0.07 and I2 = 61.5% for subgroup heterogeneity), with better results achieved with micropulse photocoagulation (MD -0.08 logMAR, 95% CI -0.16 to 0.0) as compared to the results achieved with nanopulse (MD 0.0 logMAR, 95% CI -0.06 to 0.06) and non-visible conventional (MD 0.04 logMAR, 95% CI -0.03 to 0.11), all of them compared to the standard lasers. One study reported partial to complete resolution of macular oedema at one year. There was low-certainty evidence of some benefit with standard photocoagulation, but estimates of effect were imprecise (RR 0.47, 95% CI 0.21 to 1.03; 29 eyes; 1 study). Studies also reported on the change in central macular thickness at one year and found moderate-certainty evidence of no important difference between subthreshold and standard photocoagulation (MD -9.1 μm, 95% CI -26.2 to 8.0; 385 eyes; 7 studies; I2 = 0%). There were no important adverse effects recorded in the studies.Nine studies compared argon laser versus another type of laser (997 eyes). There was moderate-certainty evidence of a small reduction or no difference between the interventions, with respect to improvement (RR 0.87, 95% CI 0.62 to 1.22; 773 eyes; 6 studies) and worsening of BCVA (RR 0.83, 95% CI 0.57 to 1.21; 773 eyes; 6 studies). Three studies reported few cases of subretinal fibrosis and neovascularization with argon laser and one study found subretinal fibrosis in the krypton group.One study (323 eyes) compared the modified ETDRS (mETDRS) grid technique with the mild macular grid (MMG), which uses mild, widely spaced burns throughout the macula. There was low-certainty evidence of an increased chance of visual improvement with MMG, but the estimate was imprecisely measured and the CIs include an increased risk or decreased risk of visual improvement at one year (RR 1.43, 95% CI 0.56 to 3.65; visual worsening: RR 1.40, 95% CI 0.64 to 3.05; change of logMAR visual acuity: MD -0.04 logMAR, 95% CI -0.01 to 0.09). There was a more significant reduction of central macular thickness with the mETDRS compared to the MMG technique (MD -34.0 µm, -59.8 to -8.3) in the MMG group. The study did not record important adverse effects.

Authors' conclusions: Laser photocoagulation reduces the chances of visual loss and increases those of partial to complete resolution of DMO compared to no intervention at one to three years. Subthreshold photocoagulation, particularly the micropulse technique, may be as effective as standard photocoagulation and RCTs are ongoing to assess whether this minimally invasive technique is preferable to treat milder or non-central cases of DMO.

PubMed Disclaimer

Conflict of interest statement

ECJ: none known. ENJ: none known. MSB: none known. JGF: none known. GV: none known. RED: none known.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD010859

References

References to studies included in this review

Akduman 1997 {published data only}
    1. Akduman L, Olk RJ. Diode laser (810 nm) versus argon green (514 nm) modified grid photocoagulation for diffuse diabetic macular edema. Ophthalmology 1997;104(9):1433‐41. - PubMed
Bandello 2005 {published data only}
    1. Bandello F, Polito A, Borrello M, Zemella N, Isola M. "Light" versus "classic" laser treatment for clinically significant diabetic macular oedema. British Journal of Ophthalmology 2005;89(7):864‐70. - PMC - PubMed
Blankenship 1979 {published data only}
    1. Blankenship GW. Diabetic macular edema and argon laser photocoagulation: a prospective randomized study. Ophthalmology 1979;86(1):69‐78. - PubMed
Casson 2012 {published data only}
    1. Casson RJ, Raymond G, Newland HS, Gilhotra JS, Gray TL. Pilot randomized trial of a nanopulse retinal laser versus conventional photocoagulation for the treatment of diabetic macular oedema. Clinical and Experimental Ophthalmology 2012;40(6):604‐10. - PubMed
Casswell 1990 {published data only}
    1. Casswell AG, Canning CR, Gregor ZJ. Treatment of diffuse diabetic macular oedema: a comparison between argon and krypton lasers. Eye 1990;4(Pt 5):668‐72. - PubMed
DRCRNET 2007 {published data only}
    1. Browning DJ, Apte RS, Bressler SB, Chalam KV, Danis RP, Davis MD, et al. Association of the extent of diabetic macular edema as assessed by optical coherence tomography with visual acuity and retinal outcome variables. Retina 2009;29(3):300‐5. - PMC - PubMed
    1. Writing Committee for the Diabetic Retinopathy Clinical Research Network, Fong DS, Strauber SF, Aiello LP, Beck RW, Callanan DG, et al. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Archives of Ophthalmology 2007;125(4):469‐80. - PMC - PubMed
ETDRS 1985 {published data only}
    1. Anonymous. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research group. Ophthalmology 1991;98(5 Suppl):766‐85. - PubMed
    1. Anonymous. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group. Archives of Ophthalmology 1995;113(9):1144‐55. - PubMed
    1. Anonymous. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report No. 4. Early Treatment Diabetic Retinopathy Research group. International Ophthalmology Clinics 1987;27(4):265‐72. - PubMed
    1. Anonymous. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Archives of Ophthalmology 1985;103(12):1796‐806. - PubMed
Figueira 2009 {published data only}
    1. Figueira J, Khan J, Nunes S, Sivaprasad S, Rosa A, Abreu JF, et al. Prospective randomised controlled trial comparing sub‐threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. British Journal of Ophthalmology 2009;93(10):1341‐4. - PubMed
Freyler 1990 {published data only}
    1. Freyler H. Laser therapy of diabetic maculopathy. A comparative study of the argon green laser and dye red laser. Klinische Monatsblätter für Augenheilkunde 1990;197(2):176‐81. - PubMed
Karacorlu 1993 {published data only}
    1. Karacorlu S, Burumcek E, Karacorlu M, Arslan O. Treatment of diabetic macular edema: a comparison between argon and dye lasers. Annals of Ophthalmology 1993;25(4):138‐41. - PubMed
Khairallah 1996 {published data only}
    1. Khairallah M, Brahim R, Allagui M, Chachia N. Comparative effects of argon green and krypton red laser photocoagulation for patients with diabetic exudative maculopathy. British Journal of Ophthalmology 1996;80(4):319‐22. - PMC - PubMed
Ladas 1993 {published data only}
    1. Ladas ID, Theodossiadis GP. Long‐term effectiveness of modified grid laser photocoagulation for diffuse diabetic macular edema. Acta Ophthalmologica 1993;71(3):393‐7. - PubMed
Laursen 2004 {published data only}
    1. Laursen ML, Moeller F, Sander B, Sjoelie AK. Subthreshold micropulse diode laser treatment in diabetic macular oedema. British Journal of Ophthalmology 2004;88(9):1173‐9. - PMC - PubMed
Lavinsky 2011 {published data only}
    1. Lavinsky D, Cardillo JA, Melo LA Jr, Dare A, Farah ME, Belfort R Jr. Randomized clinical trial evaluating mETDRS versus normal or high‐density micropulse photocoagulation for diabetic macular edema. Investigative Ophthalmology and Visual Science 2011;52(7):4314‐23. - PubMed
Olk 1986 {published data only}
    1. Olk RJ. Modified grid argon (blue‐green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 1986;93(7):938‐50. - PubMed
Olk 1990 {published data only}
    1. Olk, RJ. Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 1990;97(9):1101‐12. - PubMed
Pei‐Pei 2015 {published data only}
    1. Pei‐Pei W, Shi‐Zhou H, Zhen T, Lin L, Ying L, Jiexiong O. Randomised clinical trial evaluating best‐corrected visual acuity and central macular thickness after 532‐nm subthreshold laser grid photocoagulation treatment in diabetic macular oedema. Eye 2015;29(3):313‐21. - PMC - PubMed
Rutllan Civit 1994 {published data only}
    1. Rutllan Civit JJ, Vilaplana D, Duch F, Calvo G, Barraquer J. Grid photocoagulation for diffuse diabetic macular edema: dye‐yellow (577 nm) versus argon green (514 nm) lasers. Lasers and Light in Ophthalmology 1994;6(2):91‐7.
Striph 1988 {published data only}
    1. Striph GG, Hart WM Jr, Olk RJ. Modified grid laser photocoagulation for diabetic macular edema. The effect on the central visual field. Ophthalmology 1988;95(12):1673‐9. - PubMed
Tewari 1998 {published data only}
    1. Tewari HK, Gupta V, Kumar A, Verma L. Efficacy of diode laser for managing diabetic macular oedema. Acta Ophthalmologica Scandinavica 1998;76(3):363‐6. - PubMed
Venkatesh 2011 {published data only}
    1. Venkatesh P, Ramanjulu R, Azad R, Vohra R, Garg S. Subthreshold micropulse diode laser and double frequency neodymium: YAG laser in treatment of diabetic macular edema: a prospective, randomized study using multifocal electroretinography. Photomedicine and Laser Surgery 2011;29(11):727‐33. - PubMed
Vujosevic 2010 {published data only}
    1. Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina 2010;30(6):908‐16. - PubMed
Vujosevic 2015 {published data only}
    1. Vujosevic S, Martini F, Longhin E, Convento E, Cavarzeran F, Midena E. Subthreshold micropulse yellow laser versus subthreshold micropulse infrared laser in center‐involving diabetic macular edema: morphologic and functional safety. Retina 2015;35(8):1594‐603. - PubMed
Xie 2013 {published data only}
    1. Xie TY, Guo QQ, Wang Y, Wang Q, Chen XY. Randomized, controlled clinical trial comparison of SDM laser versus argon ion laser in diabetic macular edema [阈下微脉冲激光与氩离子激光治疗糖尿病性黄斑水肿的临床随机对照研究(英文)]. International Eye Science 2013;13(12):2370‐2.

References to studies excluded from this review

Akduman 1999 {published data only}
    1. Akduman L, Olk RJ. Subthreshold (invisible) modified grid diode laser photocoagulation in diffuse diabetic macular edema (DDME). Ophthalmic Surgery and Lasers 1999;30(9):706‐14. - PubMed
Arévalo 2013 {published data only}
    1. Arévalo JF, Fernández CF, Mendoza AJ, García RA, Arévalo FA. Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study. Archivos de la Sociedad Espanola de Oftalmologia 2013;88(10):373‐9. - PubMed
Berger 2015 {published data only}
    1. Berger A, Sheidow T, Cruess AF, Arbour JD, Courseau AS, Takacsy F. Efficacy/safety of ranibizumab monotherapy or with laser versus laser monotherapy in DME. Canadian Journal of Ophthalmology 2015;50(3):209‐16. - PubMed
Chen 2016b {published data only}
    1. Chen ZX, Fu JS, Song W, Wang CX, Zhang YL. Effect analysis of Ranibizumab with laser photocoagulation therapy for diabetic macular edema. International Eye Science 2016;16(4):706‐8.
Dong 2001 {published data only}
    1. Dong L, Wang L, Zhang S. Clinical study of grid photocoagulation in treatment of diffuse macular edema. Chinese Ophthalmic Research 2001;19(6):550‐2.
Dosso 1994 {published data only}
    1. Dosso AA, Bonvin ER, Leuenberger PM. Effectiveness of treatment of diabetic macular edema by laser photocoagulation [Efficacité du traitement de l'oedème maculaire diabétique par photocoagulation au laser]. Klinische Monatsblatter fur Augenheilkunde 1994;204(5):316‐8. - PubMed
Fang 2016 {published data only}
    1. Fang MX, Wu BB, Jia HJ. Efficacy of intravitreal injection of bevacizumab with laser photocoagulation for diabetic macular edema. International Eye Science 2016;16(5):909‐11.
Fernandez‐Vigo 1989 {published data only}
    1. Fernandez‐Vigo J, Fandino J, Fernandez MI, Salorio MS. Comparative study of efficacy of focal photocoagulation in diabetic macular edema according to the wave length used. Journal Francais d'Ophtalmologie 1989;12(11):785‐9. - PubMed
Gaudric 1984 {published data only}
    1. Gaudric A, Ramioul E, Chaine G, Coscas G. Treatment of diabetic cystoid macular edema by argon laser photocoagulation. Journal Francais d Opthalmologie 1984;7(4):291‐304. - PubMed
Huang 2016 {published data only}
    1. Huang JD, Song ZY. Clinical study of grid pattern laser photocoagulation with ranibizumab for diabetic macular edema. International Eye Science 2016;16(3):493‐5.
Inagaki 2015 {published data only}
    1. Inagaki K, Ohkoshi K, Ohde S, Deshpande GA, Ebihara N, Murakami A. Comparative efficacy of pure yellow (577‐nm) and 810‐nm subthreshold micropulse laser photocoagulation combined with yellow (561‐577‐nm) direct photocoagulation for diabetic macular edema. Japanese Journal of Ophthalmology 2015;59(1):21‐8. - PubMed
Ishibashi 2015 {published data only}
    1. Ishibashi T, Li X, Koh A, Lai TY, Lee FL, Lee WK, et al. The REVEAL study: ranibizumab monotherapy or combined with laser versus laser monotherapy in Asian patients with diabetic macular edema. Ophthalmology 2015;122(7):1402‐15. - PubMed
Ivanisević 1992 {published data only}
    1. Ivanisević M. Photocoagulation of diabetic maculopathy. Acta Medica Croatica 1992;46(2):113‐7. - PubMed
Lacava 1995 {published data only}
    1. Lacava AC, Medeiros OA, Leal EB, Caballero JC. Argon laser therapy and diabetic maculopathy. Revista Brasileira de Oftalmologia 1995;54(4):39‐43.
Lai 1996 {published data only}
    1. Lai Y, Gao R, Wu D. The study on changes of macular light sensitivity before and after photocoagulation for diabetic macular edema. Chinese Journal of Ophthalmology 1996;32(5):362‐5. - PubMed
Lee 1981 {published data only}
    1. Lee CM, Olk RJ, Akduman L. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy. American Journal of Ophthalmology 1981;92(6):762‐7. - PubMed
Lee 2000 {published data only}
    1. Lee CM, Olk RJ, Akduman L. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy. Ophthalmic Surgery and Lasers 2000;31(4):292‐300. - PubMed
Lingyan 2001 {published data only}
    1. Lingyan D, Ling W, Shisheng Z. Clinical study of grid photocoagulation in treatment of diffuse macular edema. Chinese Ophthalmic Research 2001;19(6):550‐2.
Marcus 1977 {published data only}
    1. Marcus DF, Aaberg TM. Argon laser photocoagulation treatment of diabetic cystoid maculopathy. Annals of Ophthalmology 1977;9(3):365‐72. - PubMed
Okuyama 1995 {published data only}
    1. Okuyama M, Okisaka S, Ito M. Comparative study on frequency‐doubled Nd: YAG laser, krypton laser and diode laser photocoagulation for diabetic maculopathy. Nihon Ganka Gakkai Zasshi 1995;99(1):87‐92. - PubMed
Reeser 1981 {published data only}
    1. Reeser F, Fleischman J, Williams GA, Goldman A. Efficacy of argon laser photocoagulation in the treatment of circinate diabetic retinopathy. American Journal of Ophthalmology 1981;92(6):762‐7. - PubMed
Sinclair 1999 {published data only}
    1. Sinclair SH, Alaniz R, Presti P. Laser treatment of diabetic macular edema: comparison of ETDRS‐level treatment with threshold‐level treatment by using high‐contrast discriminant central visual field testing. Seminars in Ophthalmology 1999;14(4):214‐22. - PubMed
Taylor 1977 {published data only}
    1. Taylor W. Diabetic maculopathy. Transactions of the Ophthalmological Society of New Zealand 1977;29:27‐9. - PubMed
Tomasetto 2007 {unpublished data only}
    1. Tomasetto GG, Friedman R, Gil AL, Scosso CA, Lavinsky J. Morphological evaluation of focal diabetic macular edema treated with laser photocoagulation [Avaliação morfofuncional do edema macular diabético focal tratado com fotocoagulação a laser]. Thesis 2007.
Yan 2016 {published data only}
    1. Yan P, Qian C, Wang W, Dong Y, Wan G, Chen Y. Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation. Therapeutics and Clinical Risk Management 2016;5(12):527‐33. - PMC - PubMed

References to studies awaiting assessment

Ludwig 1991 {published data only}
    1. Ludwig K, Lachenmayr BJ, Bonnici M, Plachta O. Changes in the visual field in diabetic retinopathy after grid laser coagulation of the posterior pole of the eye [Gesichtsfeldveranderungen bei diabetischer retiopathie nach GRID‐laserkoagulation des hinteren augenpols]. Fortschritte der Ophthalmologie 1991;88(6):824‐8. - PubMed

References to ongoing studies

CTRI/2015/03/005628 {published data only}
    1. CTRI/2015/03/005628. Micropulse laser versus standard laser in diabetic macular edema. ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=10767&EncHid=&am... Date first received: 12 March 2015.
ISRCTN17742985 {published data only}
    1. ISRCTN17742985. A comparison of standard laser with micropulse laser for the treatment of diabetic macular oedema. www.isrctn.com/ISRCTN17742985 Date first received: 2 May 2017.
ISRCTN66877546 {published data only}
    1. ISRCTN66877546. A prospective, randomised, double‐masked, controlled trial of the treatment of diabetic maculopathy using diode micropulsed laser versus standard argon laser. www.isrctn.com/ISRCTN66877546 Date first received: 30 September 2005.
NCT01045239 {published data only}
    1. NCT01045239. Micropulse 577 nm laser photocoagulation versus conventional 532 nm laser photocoagulation for diabetic macular oedema (UMDMO). clinicaltrials.gov/ct2/show/NCT01045239 Date first received: 8 January 2010.
NCT01928654 {published data only}
    1. NCT01928654. Comparison between treatment with yellow micropulse laser and green conventional laser in diabetic macular edema. clinicaltrials.gov/ct2/show/NCT01928654 Date first received: 27 August 2013.
NCT02309476 {published data only}
    1. NCT02309476. Sub‐threshold photocoagulation of diabetic macular oedema (MEM). clinicaltrials.gov/ct2/show/NCT02309476 Date first received: 5 December 2014.
NCT03519581 {published data only}
    1. NCT03519581. Micropulse for suppression of diabetic macular edema (PULSE). clinicaltrials.gov/ct2/show/NCT03519581 Date first received: 9 May 2018.
NCT03641144 {published data only}
    1. NCT03641144. Navigation laser versus traditional laser photocoagulation for mild diabetic macular edema. clinicaltrials.gov/ct2/show/NCT03641144 Date first received: 21 August 2018.

Additional references

Aiello 2010
    1. Aiello LP, Edwards AR, Beck RW, Bressler NM, Davis MD, Ferris F, et al. Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2010;117(5):946‐53. - PMC - PubMed
Bresnick 1986
    1. Bresnick GH. Diabetic macular edema. A review. Ophthalmology 1986;93(7):989‐97. - PubMed
Chen 2016a
    1. Chen G, Tzekov R, Li W, Jiang F, Mao S, Tong Y. Subthreshold micropulse diode laser versus conventional laser photocoagulation for diabetic macular edema: a meta‐analysis of randomized controlled trials. Retina 2016;36(11):2059‐65. - PubMed
Ciulla 2003
    1. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema. Pathophysiology, screening and novel therapies. Diabetes Care 2003;26(9):2653‐64. - PubMed
Dare 2007
    1. Dare A, Castro L, Lavinsky D, Navajas E, Cardillo JA. New horizons in the treatment of diabetic macular edema: macular photocoagulation with selective micropulse 810nm diode [Novos horizontes no tratamento do edema de macula diabético: fotocoagulaçâo macular seletiva com micropulso de diodo 810nm]. Retina e Vítreo 2007;13:16‐20.
DCCT Research Group 1995
    1. Anonymous. The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus. The Diabetes Control and Complications Trial. Archives of Ophthalmology 1995;113(1):36‐51. - PubMed
Deeks 2017
    1. Deeks JJ, Higgins JPT, Altman DG, editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s),Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook.
Dorin 2003
    1. Dorin G. Subthreshold and micropulse diode laser photocoagulation. Seminars in Ophthalmology 2003;18(3):147‐53. - PubMed
ETDRS 1987a
    1. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology 1987;94(7):761‐74. - PubMed
ETDRS 1987b
    1. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report No. 4. International Ophthalmology Clinics 1987;27(4):265‐72. - PubMed
ETDRS 1991
    1. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology 1991;98(5 Suppl):766‐85. - PubMed
ETDRS 1995
    1. Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Archives of Ophthalmology 1995;113(9):1144‐55. - PubMed
Glanville 2006
    1. Glanville JM, Lefebvre C, Miles JN, Camosso‐Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130‐6. - PMC - PubMed
GRADEpro GDT [Computer program]
    1. McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed prior to 3 August 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
Grigorian 2004
    1. Grigorian RA, Zarbin MA, Brimacombe M, Tutela A, Roy M, Bhagat N. Comparison of subthreshold micropulse diode laser photocoagulation with conventional laser photocoagulation for clinically significant macular edema in diabetic patients. Investigative Ophthalmology and Visual Science 2004;45(ARVO E‐Abstract):4067.
Grover 2008
    1. Grover DA, Li T, Chong CCW. Intravitreal steroids for macular edema in diabetes. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD005656.pub2] - DOI - PMC - PubMed
Han 1992
    1. Han DP, Mieler WF, Burton TC. Submacular fibrosis after photocoagulation for diabetic macular edema. American Journal of Ophthalmology 1992;113(5):513‐21. - PubMed
Higgins 2017
    1. Higgins JPT, Altman DG, Sterne JAC, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook.
IDF Diabetes Atlas
    1. IDF Diabetes Atlas. International Diabetes Federation. www.diabetesatlas.org/across‐the‐globe.html (accessed 12 September 2018).
Ingolf 1984
    1. Ingolf H, Wallow MD. Repair of the pigment epithelial barrier following photocoagulation. Archives of Ophthalmology 1984;102(1):126‐35. - PubMed
Lewis 1990
    1. Lewis H, Schachat AP, Haimann MH, Haller JA, Quinlan P, Fricken MA, et al. Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology 1990;97(4):503‐10. - PubMed
Lewis 1992
    1. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99(5):753‐9. - PubMed
Luttrull 2012
    1. Luttrull JK, Dorin G. Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review. Current Diabetes Reviews 2012;8(4):274‐84. - PMC - PubMed
McHugh 1990
    1. McHugh JD, Marshall J, Ffytche TJ, Hamilton AM, Raven A. Macular photocoagulation of human retina with a diode laser: a comparative histopathological study. Lasers and Light in Ophthalmology 1990;79(7):11‐28.
Neubauer 2007
    1. Neubauer AS, Ulbig MW. Laser treatment in diabetic retinopathy. Ophthalmologica 2007;221(2):95‐102. - PubMed
O'Doherty 2008
    1. O'Doherty M, Dooley I, Hickey‐Dwyer M. Interventions for diabetic macular oedema: a systematic review of the literature. British Journal of Ophthalmology 2008;92(12):1581‐90. - PubMed
Park 2014
    1. Park YG, Kim EY, Roh YJ. Laser‐based strategies to treat diabetic macular edema: history and new promising therapies. Journal of Ophthalmology 2014;2014:769213. [DOI: 10.1155/2014/769213] - DOI - PMC - PubMed
Pendergast 2000
    1. Pendergast SD, Hassan TS, Williams GA Cox MS, Margherio RR, Ferrone PJ, et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. American Journal of Ophthalmology 2000;130(2):178‐86. - PubMed
Porta 2004
    1. Porta M, Allione A. Current approaches and perspectives in the medical treatment of diabetic retinopathy. Pharmacology Therapy 2004;103(2):167‐77. - PubMed
Qiao 2016
    1. Qiao G, Guo HK, Dai Y, Wang XL, Meng QL, Li H, et al. Sub‐threshold micro‐pulse diode laser treatment in diabetic macular edema: a meta‐analysis of randomized controlled trials. International Journal of Ophthalmology 2016;9(7):1020‐7. - PMC - PubMed
Review Manager 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Reznicek 2013
    1. Reznicek L, Dabov S, Haritoglou C, Kampik A, Kernt M, Neubauer AS. Green‐light fundus autofluorescence in diabetic macular edema. International Journal of Ophthalmology 2013;6(1):75‐80. - PMC - PubMed
Schatz 1991
    1. Schatz H, Madeira D, McDonald HR, Johnson RN. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Archives of Ophthalmology 1991;109(11):549‐51. - PubMed
Scholz 2017
    1. Scholz P, Altay L, Fauser S. A review of subthreshold micropulse laser for treatment of macular disorders. Advances in Therapy 2017;34(7):1528‐55. - PMC - PubMed
Virgili 2014
    1. Virgili G, Parravano M, Menchini F, Evans JR. Anti‐vascular endothelial growth factor for diabetic macular oedema. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD007419.pub4] - DOI - PubMed
Weiter 1980
    1. Weiter JJ, Zuckerman R. The influence of the photoreceptor‐RPE complex on the inner retina: an explanation for the beneficial effects of photocoagulation. Ophthalmology 1980;87(11):1133‐39. - PubMed
Wu 2018
    1. Wu Y, Ai P, Ai Z, Xu G. Subthreshold diode micropulse laser versus conventional laser photocoagulation monotherapy or combined with anti‐VEGF therapy for diabetic macular edema: a Bayesian network meta‐analysis. Biomedicine and Pharmacotherapy 2018;97:293‐9. - PubMed

References to other published versions of this review

Jorge 2013
    1. Jorge EC, Dib R, Jorge EN. Laser photocoagulation for diabetic macular oedema. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD010859] - DOI - PMC - PubMed

Publication types

MeSH terms